Table 1.
Patient characteristics at treatment
| All | ||
|---|---|---|
| Available data | (n = 29) | |
| Age, years | 29 | 57.9 (26–77) |
| Male, n (%) | 29 | 15 (51.7) |
| Body mass index, kg/m2 | 29 | 21.7 (14.1–35.0) |
|
Risk factors, n (%) HT |
29 | 12 (41.4) |
| DL | 29 | 15 (51.7) |
| DM | 29 | 9 (31.0) |
| insulin | 29 | 4 (13.8) |
| CKD | 29 | 6 (20.7) |
| HD | 29 | 5 (17.2) |
| ex-smoke | 29 | 17 ( 58.6) |
|
Complications, n (%) IHD |
29 | 6 (20.7) |
| CVD | 29 | 4 (13.8) |
| other vascular complication | 29 | 4 (13.8) |
| Past therapy, n (%) medication | 29 | 29 (100) |
| bypass | 29 | 6 (20.7) |
| EVT | 29 | 11 (37.9) |
|
Drugs, n (%) Antiplatelet drugs |
29 | 24 (82.8) |
| Peripheral vasodilator | 29 | 20 (70.0) |
| Antihypertensive agent | 29 | 12 (41.4) |
| statin | 29 | 14 (48.3) |
| Oral hypoglycemic agent | 29 | 5 (17.2) |
Data are presented as median (interquartile range) or number (percentage).
HT hypertension; DL dyslipidemia; DM diabetes mellitus; CKD chronic kidney disease; HD hemodialysis; IHD ischemic heart disease; CVD cerebrovascular disease; EVT endovascular treatment